Protalix BioTherapeutics, Inc. Proceeds from Sale of Other Assets
Protalix BioTherapeutics, Inc. (PLX) reported Proceeds from Sale of Other Assets of $3.50 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherAssets1 · last filed 2014-11-10
- Protalix BioTherapeutics, Inc. proceeds from sale of other assets for the quarter ending 2014-09-30 was $0.00.
- Protalix BioTherapeutics, Inc. proceeds from sale of other assets for the quarter ending 2014-06-30 was $0.00.
- Protalix BioTherapeutics, Inc. proceeds from sale of other assets for the quarter ending 2014-03-31 was $3.50M.
| Period end | Proceeds from Sale of Other Assets 3 month | Proceeds from Sale of Other Assets 6 month | Proceeds from Sale of Other Assets 9 month |
|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $3.50M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $3.50M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.50M 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |